IPO Listed
Latigo Biotherapeutics IPO
US$346m raised
Lodged Aug 2026 · NASDAQ: LTGO · US$18.00 cash per share
Advisers
Lead managers
- Legal adviser
- Issuer
- Latigo Biotherapeutics
- Issuer based in
- United States
- Listed
- 7 Aug 2026
- Sector
- Biotech
- Tags
- Biotech, Pharma, Drug Development
In the league tables
Similar deals
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Suzhou Ribo Life Science Co. IPO Jan 2026 · Biotech
- Electra Therapeutics IPO Sep 2026 · US$350m · Biotech
- Avere Therapeutics placement Jul 2026 · US$320m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
Sources
- Aug 2026 Latham Watkins Advises on Latigo Biotherapeutics Upsized Initial Public Offering lw.com
- 7 Aug 2026 Final IPO prospectus (424B4), Latigo Biotherapeutics, Inc. sec.gov
- 10 Aug 2026 Latigo Biotherapeutics Announces Upsized $345.6 Million IPO cooley.com


